KLK3 and prostate carcinoma: With minimal guidance around prostate cancer diagnosis in the gender diverse community, it is important to provide evidence where there currently is none; to enable clinicians to assess the prostate cancer risk in TWNBPP and request PSA and other investigations when appropriate.